ADMA Biologics
ADMA
ADMA
95 hedge funds and large institutions have $110M invested in ADMA Biologics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
23% less capital invested
Capital invested by funds: $143M → $110M (-$32.8M)
36% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 39
Holders
95
Holding in Top 10
–
Calls
$1.6M
Puts
$2.05M
Top Buyers
| 1 | +$3.78M | |
| 2 | +$1.62M | |
| 3 | +$558K | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$522K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$346K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$2.16M | |
| 3 | -$1.83M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.21M |
| 5 |
BlackRock
New York
|
-$598K |